naproxen sodium

Generic: naproxen sodium

Labeler: p & l development, llc
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name naproxen sodium
Generic Name naproxen sodium
Labeler p & l development, llc
Dosage Form CAPSULE, LIQUID FILLED
Routes
ORAL
Active Ingredients

naproxen sodium 220 mg/1

Manufacturer
P & L Development, LLC

Identifiers & Regulatory

Product NDC 59726-174
Product ID 59726-174_2099e3fb-d761-4735-9935-c51413496741
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA208363
Marketing Start 2018-04-01
Marketing End 2026-12-31

Pharmacologic Class

Classes
anti-inflammatory agents non-steroidal [cs] cyclooxygenase inhibitors [moa] nonsteroidal anti-inflammatory drug [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59726174
Hyphenated Format 59726-174

Supplemental Identifiers

RxCUI
1112231
UPC
0359726175814
UNII
9TN87S3A3C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naproxen sodium (source: ndc)
Generic Name naproxen sodium (source: ndc)
Application Number ANDA208363 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 220 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 BOX (59726-174-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
  • 1 BOTTLE, PLASTIC in 1 BOX (59726-174-80) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
source: ndc

Packages (2)

59726-174-20 1 BOTTLE, PLASTIC in 1 BOX (59726-174-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC 59726-174-80 1 BOTTLE, PLASTIC in 1 BOX (59726-174-80) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC

Ingredients (1)

naproxen sodium (220 mg/1)

Linked Drug Pages (1)

Naproxen Sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2099e3fb-d761-4735-9935-c51413496741", "openfda": {"upc": ["0359726175814"], "unii": ["9TN87S3A3C"], "rxcui": ["1112231"], "spl_set_id": ["fc65fe79-c93b-4247-b9af-e562792a3e64"], "manufacturer_name": ["P & L Development, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (59726-174-20)  / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC", "package_ndc": "59726-174-20", "marketing_end_date": "20261231", "marketing_start_date": "20180401"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (59726-174-80)  / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC", "package_ndc": "59726-174-80", "marketing_end_date": "20261231", "marketing_start_date": "20180401"}], "brand_name": "Naproxen Sodium", "product_id": "59726-174_2099e3fb-d761-4735-9935-c51413496741", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "59726-174", "generic_name": "Naproxen Sodium", "labeler_name": "P & L Development, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA208363", "marketing_category": "ANDA", "marketing_end_date": "20261231", "marketing_start_date": "20180401"}